West Pharmaceutical Services (WST) Stock Looks Rich Against Its Cash Flow

Simply Wall St.11-02 22:15

West Pharmaceutical Services has logged a sharp share price climb so far in 2026, which puts fresh attention on what investors are really paying for in terms of its cash flows. With the stock now at ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2680765858?lang=en_US&edition=fundamental","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551728-choice2-card/1789016329041","is_english":true,"pubTime":"2026-11-02 22:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2680765858","market":"nz","top_or_hot":-1,"title":"West Pharmaceutical Services (WST) Stock Looks Rich Against Its Cash Flow","media":"Simply Wall St.","content":"<div>\n<p>West Pharmaceutical Services has logged a sharp share price climb so far in 2026, which puts fresh attention on what investors are really paying for in terms of its cash flows. With the stock now at ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-wst/west-pharmaceutical-services/news/west-pharmaceutical-services-wst-stock-looks-rich-against-it\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>West Pharmaceutical Services (WST) Stock Looks Rich Against Its Cash Flow</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWest Pharmaceutical Services (WST) Stock Looks Rich Against Its Cash Flow\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-11-02 22:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-wst/west-pharmaceutical-services/news/west-pharmaceutical-services-wst-stock-looks-rich-against-it><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>West Pharmaceutical Services has logged a sharp share price climb so far in 2026, which puts fresh attention on what investors are really paying for in terms of its cash flows. With the stock now at ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-wst/west-pharmaceutical-services/news/west-pharmaceutical-services-wst-stock-looks-rich-against-it\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00BFXG0V08.USD","symbol_name":"BNY MELLON GLOBAL LEADERS \"B\" (USD) ACC","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-wst/west-pharmaceutical-services/news/west-pharmaceutical-services-wst-stock-looks-rich-against-it","article_id":"2680765858","we_media_id":null,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/9551728-choice2-card/1789016329041"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-wst/west-pharmaceutical-services/news/west-pharmaceutical-services-wst-stock-looks-rich-against-it","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2680765858","pubTimestamp":1793628955,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"West Pharmaceutical Services has logged a sharp share price climb so far in 2026, which puts fresh attention on what investors are really paying for in terms of its cash flows. With the stock now at US$412.62, the key issue is how that market price lines up against the money the business is expected to generate over time.\n\nThe share price is up 49.3% year to date, which raises the question of whether recent enthusiasm has moved ahead of what the cash flows can support.\nRecent company updates...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00BFXG0V08.USD":"BNY MELLON GLOBAL LEADERS \"B\" (USD) ACC","LU0106261612.USD":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" ACC","BK4121":"生命科学工具和服务","LU0345774631.USD":"NINETY ONE GSF AMERICAN FRANCHISE \"A\" (USD) INC","BK4504":"桥水持仓","LU0345774391.USD":"NINETY ONE GSF AMERICAN FRANCHISE \"A\" (USD) ACC","LU0012050646.USD":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" (USD) INC AV","IE00BYQQ9H92.USD":"BNY MELLON GLOBAL LEADERS \"A\" (USD) ACC","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","SPHQ":"Invesco S&P 500 Quality ETF","IE00B64QTZ34.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) ACC","BK4588":"碎股","BK4567":"ESG概念","BK4585":"ETF&股票定投概念","WST":"West Pharmaceutical Services Inc"},"translate_title":"West Pharmaceutical Services (WST) 股票的现金流看起来很丰富","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SPHQ":0.9,"WST":1.5,"DCF":1},"content_text":"West Pharmaceutical Services has logged a sharp share price climb so far in 2026, which puts fresh attention on what investors are really paying for in terms of its cash flows. With the stock now at US$412.62, the key issue is how that market price lines up against the money the business is expected to generate over time.  The share price is up 49.3% year to date, which raises the question of whether recent enthusiasm has moved ahead of what the cash flows can support. Recent company updates highlight strong demand in key product lines and firmer profitability, which can influence how much cash West Pharmaceutical Services may be able to return to shareholders or reinvest. What if you looked at West Pharmaceutical Services through its earnings instead? See what West Pharmaceutical Services's 45.0x P/E says about the price.  The issue now is whether West Pharmaceutical Services' current valuation is justified by its cash flows when viewed through an intrinsic value lens based on those cash streams. You can apply the same cash flow question you are asking of West Pharmaceutical Services across a wider set of 36 high quality undervalued stocks AdvertisementDoes West Pharmaceutical Services Look Pricey on Cash Flow? The Discounted Cash Flow (DCF) model here rests on what West Pharmaceutical Services can generate in free cash over time. Latest twelve month free cash flow sits at about $326.7 million, and the projections used in the model assume that this stream grows steadily into the early 2030s rather than swinging sharply higher or lower from year to year. Those rising cash flow estimates are then discounted back and compared with today’s share price of US$412.62. On that basis the DCF outcome comes in meaningfully below where the stock trades. Because West Pharmaceutical Services recently reported strong Q3 2026 results and raised full year guidance, that upgraded outlook may help explain why investors currently value the shares above what these cash flow projections alone suggest. Find out what West Pharmaceutical Services could be worth using our Discounted Cash Flow (DCF) estimate. The West Pharmaceutical Services Narrative: What Would Justify Today's Price? Simply Wall St Narratives pick up where the discounted cash flow puzzle for West Pharmaceutical Services' share price leaves off, by spelling out what would need to happen to future revenue, profitability and earnings for the stock to end up worth materially more or less than it is today. Instead of a single output from a ratio or model, Narratives show the future path that number assumes so you can watch how real world results stack up over time on the Community page. One of the top community narratives on West Pharmaceutical Services: roughly fairly valued \"Bullish analysts point to West Pharmaceutical Services as a growth and margin expansion story, supported by continued strength in its high value products…\" Discover why this Narrative puts West Pharmaceutical Services at roughly fairly valued. One more check for West Pharmaceutical Services sits with who steers it Before you stop at the price tag and cash flows for West Pharmaceutical Services, it is worth asking who is steering the business and how their pay packets line up with your interests. See who runs West Pharmaceutical Services and how they are paid. This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if West Pharmaceutical Services might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2680765858","isCrawlerRequest":true}